Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Walmagh

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|June 18, 2015
Trehalose Analogues: Latest Insights in Properties and Biocatalytic ProductionMaarten Walmagh, Renfei Zhao, Tom Desmet
Current Opinion in Biotechnology|November 25, 2010
Food applications of bacterial cell wall hydrolasesLien Callewaert, Maarten Walmagh, Chris W Michiels, et al.
Plos One|May 23, 2012
Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1Maarten Walmagh, Yves Briers, Silvio Branco dos Santos, et al.
Applied Microbiology and Biotechnology|April 8, 2015
Identification of sucrose synthase in nonphotosynthetic bacteria and characterization of the recombinant enzymesMargo Diricks, Frederik De Bruyn, Paul Van Daele, et al.
Applied Microbiology and Biotechnology|July 27, 2012
Characterization of five novel endolysins from Gram-negative infecting bacteriophagesMaarten Walmagh, Barbara Boczkowska, Barbara Grymonprez, et al.
Journal of Biotechnology|July 6, 2016
Screening of recombinant glycosyltransferases reveals the broad acceptor specificity of stevia UGT-76G1Griet Dewitte, Maarten Walmagh, Margo Diricks, et al.
Plos One|October 8, 2014
A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acidsHugo Oliveira, Viruthachalam Thiagarajan, Maarten Walmagh, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaYves Briers, Maarten Walmagh, Barbara Grymonprez, et al.
Mbio|July 3, 2014
Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensYves Briers, Maarten Walmagh, Victor Van Puyenbroeck, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 18, 2015
Trehalose Analogues: Latest Insights in Properties and Biocatalytic ProductionMaarten Walmagh, Renfei Zhao, Tom Desmet
Current Opinion in Biotechnology|November 25, 2010
Food applications of bacterial cell wall hydrolasesLien Callewaert, Maarten Walmagh, Chris W Michiels, et al.
Plos One|May 23, 2012
Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1Maarten Walmagh, Yves Briers, Silvio Branco dos Santos, et al.
Applied Microbiology and Biotechnology|April 8, 2015
Identification of sucrose synthase in nonphotosynthetic bacteria and characterization of the recombinant enzymesMargo Diricks, Frederik De Bruyn, Paul Van Daele, et al.
Applied Microbiology and Biotechnology|July 27, 2012
Characterization of five novel endolysins from Gram-negative infecting bacteriophagesMaarten Walmagh, Barbara Boczkowska, Barbara Grymonprez, et al.
Journal of Biotechnology|July 6, 2016
Screening of recombinant glycosyltransferases reveals the broad acceptor specificity of stevia UGT-76G1Griet Dewitte, Maarten Walmagh, Margo Diricks, et al.
Plos One|October 8, 2014
A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acidsHugo Oliveira, Viruthachalam Thiagarajan, Maarten Walmagh, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaYves Briers, Maarten Walmagh, Barbara Grymonprez, et al.
Mbio|July 3, 2014
Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensYves Briers, Maarten Walmagh, Victor Van Puyenbroeck, et al.
Pageof 1